Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Solid Biosciences Inc shares valued at $1,909,240 were purchased by Adage Capital Management, L.P. on Feb 18 ’25. At $7.56 per share, Adage Capital Management, L.P. acquired 252,545 shares. The insider’s holdings grew to 4,248,084 shares worth approximately $25.49 million following the completion of this transaction.
Also, Hanrahan Jessie sold 3,079 shares, netting a total of over 12,193 in proceeds. Following the sale of shares at $3.96 each, the insider now holds 19,281 shares.
Before that, Brooks Gabriel had sold 3,256 shares from its account. In a trade valued at $12,894, the Chief Medical Officer traded Solid Biosciences Inc shares for $3.96 each. Upon closing the transaction, the insider’s holdings decreased to 3,256 shares, worth approximately $0.14 million.
As published in their initiating research note from Truist on January 08, 2025, Solid Biosciences Inc [SLDB] has been a Buy and the price target has been revised to $16. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid December. As of December 10, 2024, JMP Securities has initiated its “Mkt outperform” rating for SLDB. Earlier on July 15, 2024, JP Morgan upgraded its rating. Their new recommendation was “an Overweight” for SLDB stock which previously was a “a Neutral”.
Analyzing SLDB Stock Performance
During the last five days, there has been a surge of approximately 69.97%. Over the course of the year, Solid Biosciences Inc shares have jumped approximately 50.00%. Shares of the company reached a 52-week high of $7.20 on 02/18/25 and a 52-week low of $2.88 on 02/07/25. A 50-day SMA is recorded $3.92, while a 200-day SMA reached $6.54. Nevertheless, trading volume fell to 4.39 million shares from 15.29 million shares the previous day.
Support And Resistance Levels for Solid Biosciences Inc (SLDB)
According to the 24-hour chart, there is a support level at 5.60, which, if violated, would cause prices to drop to 5.20. In the upper region, resistance lies at 6.45. The next price resistance is at 6.90. RSI (Relative Strength Index) is 73.58 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.04, which suggests the price will increase in the coming days. Percent R is at 27.78%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
